:format(webp)/cdn.mskdoctors.com/storage/2026/7/qK5QIjTamPhwMv8E9NkiBLXaSBf3Bofl.jpg)
ChondroFiller for focal knee defects versus early osteoarthritisFocal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/ETKg1ueF5BBKIau7DxGIoPsVzI5r2krh.jpg)
ChondroFiller and Arthrosamid serve different knee conditionsChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
